Loading...
Loading...
Loading...
Loading...
No reviews have been added for this product.
MBL Life Sciences
| Product Specifications | |
| Application | FC |
| Reactivity | Human |
| Conjugation | PE |
| Immunogen | Mart-1 |
| Peptide Sequence | ELAGIGILTV |
| Class | Class I |
| Sequence Location | 26-35 |
| MHC Allele | A*02:01 |
| Documents & Links for HLA-A*02:01 Mart-1 Tetramer-ELAGIGILTV-PE | |
| Datasheet | HLA-A*02:01 Mart-1 Tetramer-ELAGIGILTV-PE Datasheet |
| Documents & Links for HLA-A*02:01 Mart-1 Tetramer-ELAGIGILTV-PE | |
| Datasheet | HLA-A*02:01 Mart-1 Tetramer-ELAGIGILTV-PE Datasheet |
| Citations for HLA-A*02:01 Mart-1 Tetramer-ELAGIGILTV-PE – 8 Found |
| Inozume, Takashi; Hanada, Ken-Ichi; Takeda, Kazuyo; Maeda, Tatsuo; Harada, Kazutoshi; Kawamura, Tatsuyoshi. Cytotoxic T-lymphocyte-associated protein 4 expressed by melanoma cells does not affect melanoma-specific cytotoxic T lymphocytes in the effector phase. The Journal Of Dermatology. 2019;46(1):52-56. PubMed |
| Nagano, Seiji; Maeda, Takuya; Ichise, Hiroshi; Kashima, Soki; Ohtaka, Manami; Nakanishi, Mahito; Kitawaki, Toshio; Kadowaki, Norimitsu; Takaori-Kondo, Akifumi; Masuda, Kyoko; Kawamoto, Hiroshi. High Frequency Production of T Cell-Derived iPSC Clones Capable of Generating Potent Cytotoxic T Cells. Molecular Therapy. Methods & Clinical Development. 2020;16:126-135. PubMed |
| Nagano, Seiji; Maeda, Takuya; Ichise, Hiroshi; Kashima, Soki; Ohtaka, Manami; Nakanishi, Mahito; Kitawaki, Toshio; Kadowaki, Norimitsu; Takaori-Kondo, Akifumi; Masuda, Kyoko; Kawamoto, Hiroshi. High Frequency Production of T Cell-Derived iPSC Clones Capable of Generating Potent Cytotoxic T Cells. Molecular Therapy. Methods & Clinical Development. 2020;16:126-135. PubMed |
| Nagano, Seiji; Maeda, Takuya; Ichise, Hiroshi; Kashima, Soki; Ohtaka, Manami; Nakanishi, Mahito; Kitawaki, Toshio; Kadowaki, Norimitsu; Takaori-Kondo, Akifumi; Masuda, Kyoko; Kawamoto, Hiroshi. High Frequency Production of T Cell-Derived iPSC Clones Capable of Generating Potent Cytotoxic T Cells. Molecular Therapy. Methods & Clinical Development. 2020;16:126-135. PubMed |
| Nagano, Seiji; Maeda, Takuya; Ichise, Hiroshi; Kashima, Soki; Ohtaka, Manami; Nakanishi, Mahito; Kitawaki, Toshio; Kadowaki, Norimitsu; Takaori-Kondo, Akifumi; Masuda, Kyoko; Kawamoto, Hiroshi. High Frequency Production of T Cell-Derived iPSC Clones Capable of Generating Potent Cytotoxic T Cells. Molecular Therapy. Methods & Clinical Development. 2020;16:126-135. PubMed |
| Akiyama, Yasuto; Tanosaki, Ryuji; Inoue, Naoki; Shimada, Makiko; Hotate, Yukie; Yamamoto, Akifumi; Yamazaki, Naoya; Kawashima, Ichiro; Nukaya, Ikuei; Takesako, Kazutoh; Maruyama, Kouji; Takaue, Yoichi; Yamaguchi, Ken. Clinical response in Japanese metastatic melanoma patients treated with peptide cocktail-pulsed dendritic cells. Journal Of Translational Medicine. 2005;3(1):4. PubMed |
| Takahara, Masashi; Miyai, Manami; Tomiyama, Mai; Mutou, Masato; Nicol, Andrew J; Nieda, Mie. Copulsing tumor antigen-pulsed dendritic cells with zoledronate efficiently enhance the expansion of tumor antigen-specific CD8+ T cells via Vgamma9gammadelta T cell activation. Journal Of Leukocyte Biology. 2008;83(3):742-54. PubMed |
| Tomiyama, Mai; Takahara, Masashi; Egawa, Kohji; Nieda, Mie. Mature dendritic cells are superior to immature dendritic cells in expanding antigen-specific naive and memory CD8+ T cells. Anticancer Research. 2004;24(5C):3327-33. PubMed |
MBL Life Sciences
| Product Specifications | |
| Application | FC |
| Reactivity | Human |
| Conjugation | PE |
| Immunogen | Mart-1 |
| Peptide Sequence | ELAGIGILTV |
| Class | Class I |
| Sequence Location | 26-35 |
| MHC Allele | A*02:01 |
| Documents & Links for HLA-A*02:01 Mart-1 Tetramer-ELAGIGILTV-PE | |
| Datasheet | HLA-A*02:01 Mart-1 Tetramer-ELAGIGILTV-PE Datasheet |
| Documents & Links for HLA-A*02:01 Mart-1 Tetramer-ELAGIGILTV-PE | |
| Datasheet | HLA-A*02:01 Mart-1 Tetramer-ELAGIGILTV-PE Datasheet |
| Citations for HLA-A*02:01 Mart-1 Tetramer-ELAGIGILTV-PE – 8 Found |
| Inozume, Takashi; Hanada, Ken-Ichi; Takeda, Kazuyo; Maeda, Tatsuo; Harada, Kazutoshi; Kawamura, Tatsuyoshi. Cytotoxic T-lymphocyte-associated protein 4 expressed by melanoma cells does not affect melanoma-specific cytotoxic T lymphocytes in the effector phase. The Journal Of Dermatology. 2019;46(1):52-56. PubMed |
| Nagano, Seiji; Maeda, Takuya; Ichise, Hiroshi; Kashima, Soki; Ohtaka, Manami; Nakanishi, Mahito; Kitawaki, Toshio; Kadowaki, Norimitsu; Takaori-Kondo, Akifumi; Masuda, Kyoko; Kawamoto, Hiroshi. High Frequency Production of T Cell-Derived iPSC Clones Capable of Generating Potent Cytotoxic T Cells. Molecular Therapy. Methods & Clinical Development. 2020;16:126-135. PubMed |
| Nagano, Seiji; Maeda, Takuya; Ichise, Hiroshi; Kashima, Soki; Ohtaka, Manami; Nakanishi, Mahito; Kitawaki, Toshio; Kadowaki, Norimitsu; Takaori-Kondo, Akifumi; Masuda, Kyoko; Kawamoto, Hiroshi. High Frequency Production of T Cell-Derived iPSC Clones Capable of Generating Potent Cytotoxic T Cells. Molecular Therapy. Methods & Clinical Development. 2020;16:126-135. PubMed |
| Nagano, Seiji; Maeda, Takuya; Ichise, Hiroshi; Kashima, Soki; Ohtaka, Manami; Nakanishi, Mahito; Kitawaki, Toshio; Kadowaki, Norimitsu; Takaori-Kondo, Akifumi; Masuda, Kyoko; Kawamoto, Hiroshi. High Frequency Production of T Cell-Derived iPSC Clones Capable of Generating Potent Cytotoxic T Cells. Molecular Therapy. Methods & Clinical Development. 2020;16:126-135. PubMed |
| Nagano, Seiji; Maeda, Takuya; Ichise, Hiroshi; Kashima, Soki; Ohtaka, Manami; Nakanishi, Mahito; Kitawaki, Toshio; Kadowaki, Norimitsu; Takaori-Kondo, Akifumi; Masuda, Kyoko; Kawamoto, Hiroshi. High Frequency Production of T Cell-Derived iPSC Clones Capable of Generating Potent Cytotoxic T Cells. Molecular Therapy. Methods & Clinical Development. 2020;16:126-135. PubMed |
| Akiyama, Yasuto; Tanosaki, Ryuji; Inoue, Naoki; Shimada, Makiko; Hotate, Yukie; Yamamoto, Akifumi; Yamazaki, Naoya; Kawashima, Ichiro; Nukaya, Ikuei; Takesako, Kazutoh; Maruyama, Kouji; Takaue, Yoichi; Yamaguchi, Ken. Clinical response in Japanese metastatic melanoma patients treated with peptide cocktail-pulsed dendritic cells. Journal Of Translational Medicine. 2005;3(1):4. PubMed |
| Takahara, Masashi; Miyai, Manami; Tomiyama, Mai; Mutou, Masato; Nicol, Andrew J; Nieda, Mie. Copulsing tumor antigen-pulsed dendritic cells with zoledronate efficiently enhance the expansion of tumor antigen-specific CD8+ T cells via Vgamma9gammadelta T cell activation. Journal Of Leukocyte Biology. 2008;83(3):742-54. PubMed |
| Tomiyama, Mai; Takahara, Masashi; Egawa, Kohji; Nieda, Mie. Mature dendritic cells are superior to immature dendritic cells in expanding antigen-specific naive and memory CD8+ T cells. Anticancer Research. 2004;24(5C):3327-33. PubMed |
